Why Salesforce.com (CRM) Dipped More Than Broader Market Today

Salesforce.com (CRM) shares recently declined 2.57% to $256.64, underperforming major market indices, despite having previously outpaced the broader technology sector. Ahead of its upcoming earnings report, analysts project EPS of $2.85, an 18.26% year-over-year increase, on $10.26 billion in revenue, up 8.68%. The stock, currently holding a Zacks Rank #3 (Hold), appears relatively undervalued with a Forward P/E of 23.22 and a PEG ratio of 1.67, both trading below its industry averages of 28.81 and 2.1, respectively.

Analysis

Salesforce.com (CRM) experienced a significant daily decline of 2.57% to $256.64, notably underperforming the broader market indices, including the S&P 500's 0.53% loss. This recent dip contrasts with its prior performance, where CRM shares had gained 7.71%, outpacing both the Computer and Technology sector and the S&P 500. This suggests a short-term correction against a backdrop of prior outperformance.

Ahead of its earnings disclosure, CRM is projected to report EPS of $2.85, an 18.26% year-over-year increase, on revenue of $10.26 billion, representing 8.68% growth. Full-year estimates also indicate robust growth, with EPS at $11.35 (+11.27% YOY) and revenue at $41.21 billion (+8.76% YOY). The Zacks Consensus EPS estimate has seen a 1.8% increase over the last 30 days, reflecting a moderately positive analyst outlook, though the stock currently holds a Zacks Rank #3 (Hold).

CRM appears attractively valued compared to its industry, with a Forward P/E of 23.22 against an industry average of 28.81. Its PEG ratio of 1.67 also stands below the Computer - Software industry's average of 2.1, suggesting potential undervaluation relative to its growth prospects. However, the Computer - Software industry itself holds a Zacks Industry Rank of 145, placing it in the bottom 42% of all industries, which could present a broader sector headwind.

Key Decisions for Investors

• Consider the recent underperformance as a potential entry point given the stock's relative valuation discount and strong earnings growth projections.
• Monitor the upcoming earnings report closely for confirmation of projected growth rates and any management guidance, as analyst estimate revisions directly correlate with future stock performance.
• Evaluate CRM's performance within the context of its lower-ranked industry, recognizing that broader sector weakness could temper individual stock gains despite strong fundamentals.